Related Experiment Video
Updated: Mar 7, 2026
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Low-Density Lipoprotein Cholesterol (LDL-C): How Low?
1Wethington Building, 900 South Limestone Street, Lexington, KY 40536-0200. United States.
Insights
Lowering low-density lipoprotein cholesterol (LDL-C) is crucial for cardiovascular health. Very low LDL-C levels, potentially as low as 20 mg/dL, may be safe and beneficial for high-risk patients with extensive atherosclerosis.
Area of Science:
- Cardiology
- Lipidology
- Preventive Medicine
Background:
- Low-density lipoprotein cholesterol (LDL-C) is a primary risk factor for cardiovascular disease.
- Therapeutic lowering of LDL-C reduces atherosclerotic events.
- Individualized LDL-C targets are essential, considering baseline levels and patient risk.
Purpose of the Study:
- To investigate the safety and justification of very low LDL-C levels in high-risk cardiovascular patients.
- To explore the clinical implications of achieving extremely low LDL-C through various means.
- To provide context on the
Main Methods:
- Literature review and synthesis of available clinical evidence.
- Discussion of clinical scenarios associated with naturally very low LDL-C.
- Contextualization of therapeutic strategies for LDL-C reduction.
Main Results:
- Certain conditions (e.g., PCSK9 mutations, hypobetalipoproteinemia) are linked to very low LDL-C in healthy individuals.
- A therapeutic target of LDL-C as low as 20 mg/dL may be justifiable in specific high-risk populations.
- No definitive universal safe lower limit for LDL-C can be established.
Conclusions:
- Very low LDL-C levels (around 20 mg/dL) can be considered in patients with extensive atherosclerosis requiring plaque stabilization and regression.
- Clinical decisions on LDL-C targets should be individualized based on risk and potential benefits.
- Further research may be needed to define precise safe thresholds for LDL-C.
Abstract:
Low-density lipoprotein cholesterol (LDL-C) is a well-established major cardiovascular (CV) risk factor supported by clinical evidence showing decreased atherosclerotic disease events when LDL-C is therapeutically lowered. A reasonable approach is to tailor each patient's LDL-C target level depending on the initial LDL-C level and the perceived risk. Multiple clinical entities such as the newborn, hypobetalipoproteinemia, proprotein convertase subtilisin/kexin type 9 (PCSK9) missense mutations, and an unexpected excess response to a statin or other medications, are associated with very low LDL-C levels in otherwise healthy individuals. Therefore, an issue of major interest to clinicians who buy into "lower is better" for LDL-C in the high-risk CV patient is how low can and should the LDL-C be taken? Available information is discussed and placed into context. A definite safe lowest LDL-C level cannot be specified but there appears to be support that a level as low as 20 mg/dL (0.52 mmol/l) can be justified in the highest CV risk patients with extensive atherosclerosis where plaque stabilization and regression are necessary.
Related Concept Videos
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:18Lipids: Dietary Sources and Requirements
01:29Cholesterol: Significance and Regulation
Considering cholesterol and...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:26Coronary Artery Disease IV: Preventive Measures
01:26Atherosclerosis III: Management